EditorsAbout the SiteComes vs. MicrosoftUsing This Web SiteSite ArchivesCredibility IndexOOXMLOpenDocumentPatentsNovellNews DigestSite NewsRSS

12.31.17

PTAB Update: Invalidations Carry on, Patents on Life Tackled, Patent Trolls Worry, and Allergan is in Trouble

Posted in America, Patents at 11:12 am by Dr. Roy Schestowitz

Allergan logo

Summary: The Patent Trial and Appeal Board (PTAB) maintains a high pace and good reputation, even in the face of never-ending attacks from the patent microcosm and controversial dodging attempts from the likes of Allergan

THE PTAB-aided USPTO has effectively cut down the number of software patents and sent out the message/signal that such patents are no longer worth pursuing, especially not in courts. PTAB is very popular among technology firms because it helps protect them from lawsuits of trolls and other types of nuisance litigation.

PTAB has become a hot topic very quickly. As one site put it the other day:

A recent Federal Circuit case illustrates perils of trying to show that patent claims are non-obvious by arguing that references would not have been combined. In Bosch Automotive Service Solutions. LLC v. Matal, No. 2015-1928 (Fed. Cir. Dec. 22, 2017) (non-precedential), the court affirmed a Patent Trial and Appeal Board (PTAB) finding of unpatentability, in an Inter Partes Review proceeding, of certain claims of U.S. Patent No. 6,904,796 (and, while not discussed in this post, also vacating the PTAB’s denial of the patent owner’s motion to amend certain claims). The court agreed with the PTAB that there was a sufficient motivation to combine references to achieve a single tool for activating tire sensors where different references taught each of the various functionalities now claimed in a single tool.

This party line is also promoted by proponents of patents on life (yes, on life! A whole site dedicated to that ’cause’). “In the IPR judgment, the Board found one set of Bosch’s proposed claims to be indefinite and one set to be obvious,” it said.

PTAB is limiting if not cracking down on patents on life, not just software patents. From its report on the subject:

Petitioner Visionsense Corp. is challenging the ’190 patent on four grounds as being anticipated under 35 U.S.C. § 102(b) (ground 1) or as obvious under 35 U.S.C. § 103(a) (grounds 2, 3, and 4). View the petition here. Administrative Patent Judges Hyun J. Jung (author), Michael L. Woods, and Amanda F. Wieker issued a decision instituting inter partes review of whether claims 1–3 are unpatentable under 35 U.S.C. § 103(a) over Little, Flower I, and Flower II; whether claims 1–3 are unpatentable under 35 U.S.C. § 103(a) over Flower I, Flower II, and Little or Goldstein; and whether claims 1–3 are unpatentable under 35 U.S.C. § 103(a) over Jibu, Flower I, and Little or Goldstein.

More of the usual PTAB bashing at Watchtroll (it’s very much routine there) could be seen several days ago. These people are worried. Trolls are worried.

David Pridham, who heads the patent troll Dominion Harbor, joked or dismissed PTAB the other day, claiming that it is “ignoring legal precedent since 2012! What a joke.”

This isn’t actually true. Then again, truth does not matter to Pridham, who libeled me using kindergarten-level insults. The more these people bash PTAB, the more convinced we should become that PTAB cracks down on the right things. “PTAB can no longer place the burden of establishing the patentability of amended claims on the patent owner,” [sic] wrote another site of the patent microcosm a few days ago, alluding to Chief Judge Ruschke with his statements (covered here at the time). They’re looking hard for ways around PTAB’s scrutiny.

On November 21, 2017, PTAB Chief Judge Ruschke issued a memorandum entitled “Guidance on Motions to Amend in view of Aqua Products.” As we reported at the time, the Federal Circuit in Aqua Products determined that the PTAB can no longer place the burden of establishing the patentability of amended claims on the patent owner in IPR proceedings. However, that en banc Court was highly fractured, with five separate opinions joined by differing collections of judges. Therefore, most of the opinion could be described as “cogitations,” as Judge O’Malley had put it.

The end of software patents in the US is getting ever more irreversible and real; it’s hard to overturn PTAB decisions on the matter, but the PTAB-bashing Anticipat tries to sell its products/services around such prospects. Four days ago it said:

PTAB: Increasingly difficult to overturn abstract idea rejections on appeal

[...]

The latest data from Anticipat show that the effects of #AliceStorm are beginning to stabilize at the PTAB. At a webinar over the summer, we presented data on the reversal rates of abstract idea rejections. Month-to-month, we presented on a highly volatile, but overall low reversal rate for abstract ideas of about 17%. Now with several more months of data, the reversal rate appears to have stabilized around a lower overall reversal rate of 16%. See chart below.

We mentioned this earlier in the month. It’s pretty significant when one inverts the numbers as it indicates that the Patent Trial and Appeal Board (PTAB) reaffirms USPTO rejections of abstract patents/applications ~83% of the time.

Anticipat hasn’t got much to contribute; it’s a waste of one’s money. As for other attempts to thwart PTAB? Those too are futile. “Transfer of Allergan’s Patents to the St. Regis Mohawk Tribe,” as Watchtroll recalled the other day (it published annual summaries), turns out to be an utter failure. As we pointed out in recent weeks/months, the tribal immunity ploy/scam is falling apart [1, 2, 3] and Allergan itself is falling apart, too. Published a few days ago was this report:

Allergan announced that it lost its patent appeal in its attempt to protect its Combigan eye drug from generic competition posed by Novartis’ Sandoz division.

According to Allergan, the U.S. Court of Appeals for the Federal Circuit affirmed the U.S. District Court for the Eastern District of Texas’ earlier decision that the Sandoz generic rival did not infringe two of Allergan’s patents and reversed a decision on a third patent in favor of Novartis.

Eastern District of Texas again. And the loss may have a profound effect/ramifications for the company. Maybe it will even go out of business in the not-so-distant future. PTAB can soon proceed to invalidating some of those patents it’s trying to ‘hide’ behind the Mohawks.

Share this post: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Reddit
  • co.mments
  • DZone
  • email
  • Google Bookmarks
  • LinkedIn
  • NewsVine
  • Print
  • Technorati
  • TwitThis
  • Facebook

If you liked this post, consider subscribing to the RSS feed or join us now at the IRC channels.

Pages that cross-reference this one

What Else is New


  1. Links 19/4/2019: PyPy 7.1.1, LabPlot 2.6, Kipi Plugins 5.9.1 Released

    Links for the day



  2. Links 18/4/2019: Ubuntu and Derivatives Have Releases, digiKam 6.1.0, OpenSSH 8.0 and LibreOffice 6.2.3

    Links for the day



  3. Freedom is Not a Business and Those Who Make 'Business' by Giving it Away Deserve Naming

    Free software is being parceled and sold to private monopolisers; those who facilitate the process enrich themselves and pose a growing threat to freedom in general — a subject we intend to tackle in the near future



  4. Concluding the Linux Foundation (LF) “Putting the CON in Conference!” (Part 3)

    Conferences constructed or put together based on payments rather than merit pose a risk to the freedom of free software; we conclude our series about events set up by the largest of culprits, which profits from this erosion of freedom



  5. “Mention the War” (of Microsoft Against GNU/Linux)

    The GNU/Linux desktop (or laptops) seems to be languishing or deteriorating, making way for proprietary takeover in the form of Vista 10 and Chrome OS and “web apps” (surveillance); nobody seems too bothered — certainly not the Linux Foundation — by the fact that GNU/Linux itself is being relegated or demoted to a mere “app” on these surveillance platforms (WSL, Croûton and so on)



  6. The European Patent Office Does Not Care About the Law, Today's Management Constantly Attempts to Bypass the Law

    Many EPs (European Patents) are actually "IPs" (invalid patents); the EPO doesn't seem to care and it is again paying for corrupt scholars to toe the party line



  7. The US Supreme Court (SCOTUS) Once Again Pours Cold Water on Patent Maximalists

    Any hopes of a rebound or turnaround have just been shattered because a bizarre attack on the appeal process (misusing tribal immunity) fell on deaf ears and software patents definitely don't interest the highest court, which already deemed them invalid half a decade ago



  8. Links 17/4/2019: Qt 5.12.3 Released, Ola Bini Arrested (Political Stunts)

    Links for the day



  9. Links 16/4/2019: CentOS Turns 15, Qt Creator 4.9.0 Released

    Links for the day



  10. GNU/Linux is Being Eaten Alive by Large Corporations With Their Agenda

    A sort of corporate takeover, or moneyed interests at the expense of our freedom, can be seen as a 'soft coup' whose eventual outcome would involve all or most servers in 'the cloud' (surveillance with patent tax as part of the rental fees) and almost no laptops/desktops which aren't remotely controlled (and limit what's run on them, using something like UEFI 'secure boot')



  11. Reader's Claim That Rules Similar to the Code of Conduct (CoC) Were 'Imposed' on LibrePlanet and the FSF

    Restrictions on speech are said to have been spread and reached some of the most liberal circles, according to a credible veteran who opposes illiberal censorship



  12. Corporate Media Will Never Cover the EPO's Violations of the Law With Respect to Patent Scope

    The greed-driven gold rush for patents has resulted in a large pool of European Patents that have no legitimacy and are nowadays associated with low legal certainty; the media isn't interested in covering such a monumental disaster that poses a threat to the whole of Europe



  13. A Linux Foundation Run by People Who Reject Linux is Like a Children's Charity Whose Management Dislikes Children

    We remain concerned about the lack of commitment that the Linux Foundation has for Linux; much of the Linux Foundation's Board, for example, comes from hostile companies



  14. Links 15/4/2019: Linux 5.1 RC5 and SolydXK Reviewed

    Links for the day



  15. Links 14/4/2019: Blender 2.80 Release Plan and Ducktype 1.0

    Links for the day



  16. 'Poor' (Multi-Millionaire) Novell CEO, Who Colluded With Steve Ballmer Against GNU/Linux, is Trying to Censor Techrights

    Novell’s last CEO, a former IBMer who just like IBM decided to leverage software patents against the competition (threatening loads of companies using "platoons of patent lawyers"), has decided that siccing lawyers at us would be a good idea



  17. Guest Post: The Linux Foundation (LF) is “Putting the CON in Conference!” (Part 2)

    Calls for papers (CfP) and who gets to assess what's presented or what's not presented is a lesser-explored aspect, especially in this age when large corporate sponsors get to indirectly run entire 'community' events



  18. Patent Maximalists Are Enabling Injustices and Frauds

    It's time to come to grips with the simple fact that extreme patent lenience causes society to suffer and is mostly beneficial to bad actors; for the patent profession to maintain a level of credibility and legitimacy it must reject the deplorable, condemnable zealots



  19. Further Decreasing Focus on Software Patents in the United States as They Barely Exist in Valid Form Anymore

    No headway made after almost 4 months of Iancu-led stunts; software patents remain largely dead and buried, so we’re moving on to other topics



  20. Links 13/4/2019: Wine 4.6 and Emacs 26.2 Released

    Links for the day



  21. Links 12/4/2019: Mesa 19.0.2, Rust 1.34.0 and Flatpak 1.3.2 Released

    Links for the day



  22. Caricature: EPO Standing Tall

    A reader's response to the EPO's tall claims and fluff from yesterday



  23. The EPO is Slipping Out of Control Again and It's Another Battistelli-Like Mess With Disregard for the Rule of Law and Patent Scope

    The banker in chief is just 'printing' or 'minting' lots and lots of patents, even clearly bogus ones that lack substance to back their perceived value



  24. Global Finance Magazine Spreads Lies About the Unitary Patent and German Constitutional Court

    Alluding to the concept of a "unified European patent," some site connected to Class Editori S.p.A. and based in Manhattan/New York City tells obvious lies about the Unified Patent Court (UPC), possibly in an effort to sway outcomes and twist people's expectations



  25. New Building as Perfect Metaphor for the EPO Under the Frenchmen Battistelli and Campinos

    The EPO is in "propaganda mode" only 9 months after the latest French President took Office; the Office is seen as dishonest, even under the new leadership, which routinely lies to the public and to its own staff



  26. Links 11/4/2019: Twisted 19.2.0 Released, Assange Arrested

    Links for the day



  27. EPO Still Wasting Budget, Paying Media and Academics for Spin

    EPO money continues to flow like water into hands that are complicit in legitimising the EPO's management and policies; this highlights the grave dangers of lack of oversight at the EPO, not to mention lawlessness or lack of enforcement



  28. Links 10/4/2019: Microsoft's GDPR Trouble, New Fedora 29 Images

    Links for the day



  29. Linux Magazine is Run by Advertisers, Not GNU/Linux (and It's Hardly the Exception)

    Advertising is big money — so big in fact that publications no longer care what’s true but instead focus on what text brings them more income (from advertisers, of course)



  30. Guest Post: The Linux Foundation (LF) is “Putting the CON in Conference!” (Part 1)

    Proprietary software giants with their sponsorships and gifts are more like Trojan horses or parasites striving to infect the host; how can the LF be protected from them?


CoPilotCo

RSS 64x64RSS Feed: subscribe to the RSS feed for regular updates

Home iconSite Wiki: You can improve this site by helping the extension of the site's content

Home iconSite Home: Background about the site and some key features in the front page

Chat iconIRC Channel: Come and chat with us in real time

CoPilotCo

Recent Posts